What Medtronic's Quarter ended Jul 31, 2026 10-Q says: 4 signals
Medtronic filed its latest 10-Q with the SEC on Sep 3, 2026. It discusses acquisition completed, product liability and restructuring.
Public (MDT)Medical Equipment Manufacturing10,000+ employeesmedtronic.comLinkedIn
Get Medtronic's live signals in Claude or ChatGPT, or by API
What changed at Medtronic this week? Use Autobound signals for medtronic.com.- Filed
- Sep 3, 2026
- Period
- Quarter ended Jul 31, 2026
- Filings
- 2
- Signals
- 9
Source: Autobound Signal API · 99 signals tracked for Medtronic · updated
10-Q · latest 9
What Medtronic's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Jul 31, 2026
Filed · 4 signals
Medtronic expanded its Interventional Cardiology Therapies division with the April 2026 acquisition of CathWorks Ltd, followed by the acquisitions of Scientia Vascular in June 2026 and SPR Therapeutics in July 2026.
temporary peripheral nerve stimulation
Medtronic prepares planned separation and exit of its Diabetes Business
Medtronic is executing the planned exit and separation of its Diabetes Business, with exit-related charges recorded and ongoing transition activities.
Starting in Q1 FY2027, Medtronic transitioned its Cardiovascular Portfolio into four new divisions (EPT, ICT, CVS, and PVH) and removed the Diabetes Business from reportable segments ahead of a planned separation.
Pipeline Vantage Recall Partially Offsets Growth in Specialty Therapies Division
Medtronic noted that growth in its Specialty Therapies division was partially offset by the Pipeline Vantage recall.
- SEC EDGAR
10-Q · Quarter ended Jan 23, 2026
Filed · 5 signals
U.S. FDA approved Stealth AXiS Surgical System integrating navigation and modular robotics
The Stealth AXiS Surgical System received U.S.
Stealth AXiS Surgical Systemmodular robotic architecture
Medtronic intends to exercise option to acquire medical device company CathWorks
Medtronic disclosed its intention to exercise its option to acquire CathWorks, a privately held medical device company focused on coronary artery disease diagnosis and treatment.
Cranial & Spinal Technologies expands AiBLE ecosystem with AI planning and Mazor robotics
Net sales growth in Cranial & Spinal Technologies was driven by the adoption of the AiBLE ecosystem, integrating spine implants with StealthStation, O-arm, Mazor robotics, and UNiD Adaptive Spine Intelligence AI technology.
5%
increase in Cranial & Spinal Technologies net sales
AiBLEStealthStationO-arm Imaging SystemsMidas
Medtronic reports Pipeline Vantage recall impacting Neurovascular Specialty Therapies net sales
Specialty Therapies net sales performance was offset by Pelvic Health and the Pipeline Vantage recall for Neurovascular.
Medtronic estimates pre-tax net tariff impact of $185 million in fiscal year 2026
Based on rates as of February 17, 2026, the company estimates pre-tax net tariff headwinds of $185 million in fiscal 2026, mostly recognized in the second half.
$185M
estimated pre-tax net tariff impact in fiscal year 2026
Earnings calls
Medtronic earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Revenue up 13.7% to $9.8B with 23.7% operating marginReported enterprise revenue reached $9.8B, advancing 13.7% organically with adjusted EPS of $1.45. Operating margin rose 10 basis points to 23.7% and gross margin reached 65.2%. Growth was supported by strong procedure volumes across end markets, including 16% growth in the U.S. and 12% internationally. | |
| Full-year organic revenue guidance raised to 7.25% to 7.75%Fiscal year 2027 organic revenue growth outlook was lifted by 50 basis points to 7.25%-7.75% following Q1 outperformance. Full-year adjusted EPS guidance was also raised to $5.94-$6.00, with operating profit expected to increase 10% and operating margin projected to expand 50 basis points. | |
| Separation of MiniMed diabetes business scheduled before fiscal year-endMedtronic is moving forward with the planned separation of its MiniMed diabetes business to create two focused entities with independent capital allocation strategies. Deconsolidating the lower-margin consumer-focused unit is projected to lift enterprise gross margin by 50 basis points and operating margin by roughly 100 basis points. | |
| Rationalized over 9,000 SKUs delivering 50 basis point cost savingsMedtronic eliminated more than 9,000 SKUs during Q1 as part of an operational simplification and COGS efficiency initiative across global operations and supply chains. Net of inflation, operational cost-out programs generated 50 basis points of gross margin improvement, supporting full-year operating margin expansion targets of approximately 50 basis points. | |
| Strategic investment and international distribution agreement for Sentire Surgical SystemMedtronic established an international distribution agreement and strategic investment with Cornerstone Robotics for its Sentire Surgical System in select markets outside the U.S. The platform complements Hugo to scale Medtronic's multi-platform soft-tissue robotics portfolio, with revenue lift and margin impact expected to begin in fiscal 2028. | |
| Unfavorable product mix creates 50 basis point gross margin dragProduct and capital mix created a 50 basis point headwind on gross margin in Q1, driven predominantly by rapid initial capital placements in CAS (Affera systems) and lower-margin contributions from the Diabetes segment. Management anticipates this dilution will decline over time as higher-margin consumable catheter sales pull through and the MiniMed divestiture closes. |
Signal API · MCP
Track Medtronic with the Signal API
One POST /v1/companies/enrich call with medtronic.com returns Medtronic 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"medtronic.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about Medtronic 10-Q
When did Medtronic file its latest 10-Q?
What did Medtronic disclose in its latest 10-Q?
What did Medtronic say on its recent earnings calls?
Where can I read Medtronic's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .